Association between main caspase gene polymorphisms and the susceptibility and prognosis of colorectal cancer

Medical Oncology

Volumn 30, Issue 3, 2013, Pages

  Wu, Zhiwei ^a   Li, Ye ^a   Li, Shuying ^a   Zhu, Lin ^a   Li, Guangxiao ^a   Yu, Zhifu ^a   Zhao, Xiaojuan ^a   Ge, Jie ^a   Cui, Binbin ^a   Dong, Xinshu ^a   Tian, Suli ^a   Hu, Fulan ^a   Zhao, Yashuang ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Caspase; Colorectal cancer; Polymorphism; Prognosis

Indexed keywords

CASPASE; CASPASE 3; CASPASE 8; CASPASE 9;

ADULT; ARTICLE; CANCER PROGNOSIS; COLORECTAL CANCER; CONTROLLED STUDY; ENVIRONMENTAL FACTOR; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECTUM CANCER; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE STRAND CONFORMATION POLYMORPHISM; ASIAN CONTINENTAL ANCESTRY GROUP; CASE CONTROL STUDY; COLORECTAL TUMOR; GENETIC PREDISPOSITION; GENETICS; PROGNOSIS; RISK; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; ASIAN;

ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CASPASES; COLORECTAL NEOPLASMS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; RISK; RISK FACTORS;

EID: 84878139238     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-013-0565-0     Document Type: Article

References (35)

1. Abuli A, Fernandez-Rozadilla C, Giraldez MD, Munoz J, Gonzalo V, Bessa X, et al. A two-phase case-control study for colorectal cancer genetic susceptibility: candidate genes from chromosomal regions 9q22 and 3q22. Br J Cancer. 2011;105(6): 870-5. doi:10.1038/bjc.2011.296.
2. http://globocan.iarc.fr/factsheets/cancers/colorectal.asp.
3. Kinzler KW, Vogelstein B. Lessons from hereditary colorectal cancer. Cell. 1996;87(2):159-70.
4. Theodoropoulos GE, Gazouli M, Vaiopoulou A, Leandrou M, Nikouli S, Vassou E, et al. Polymorphisms of caspase 8 and caspase 9 gene and colorectal cancer susceptibility and prognosis. Int J Colorectal Dis. 2011;26(9):1113-8. doi:10.1007/s00384-011-1217-5.
5. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science. 1995;267(5203):1456-62.
6. Raff M. Cell suicide for beginners. Nature. 1998;396(6707): 119-22. doi:10.1038/24055.
7. Budihardjo I, Oliver H, Lutter M, Luo X, Wang X. Biochemical pathways of caspase activation during apoptosis. Annu Rev Cell Dev Biol. 1999;15:269-90. doi:10.1146/annurev.cellbio.15.1.269.
8. Nicholson DW, Thornberry NA. Caspases: killer proteases. Trends Biochem Sci. 1997;22(8):299-306. doi:10.1016/S0968-0004(97)01085-2.
9. Degterev A, Boyce M, Yuan J. A decade of caspases. Oncogene. 2003;22(53):8543-67. doi:10.1038/sj.onc.1207107.
10. Ashkenazi A, Dixit VM. Apoptosis control by death and decoy receptors. Curr Opin Cell Biol. 1999;11(2):255-60.
11. Slee EA, Adrain C, Martin SJ. Executioner caspase-3, -6, and -7 perform distinct, non-redundant roles during the demolition phase of apoptosis. J Biol Chem. 2001;276(10):7320-6. doi:10.1074/jbc. M008363200.
12. Grabe N. AliBaba2: context specific identification of transcription factor binding sites. In Silico Biol. 2002;2(1):S1-15.
13. Koomagi R, Volm M. Relationship between the expression of caspase-3 and the clinical outcome of patients with non-small cell lung cancer. Anticancer Res. 2000;20(1B):493-6.
14. Tormanen-Napankangas U, Soini Y, Kahlos K, Kinnula V, Paakko P. Expression of caspases-3, -6 and -8 and their relation to apoptosis in non-small cell lung carcinoma. Int J Cancer. 2001; 93(2):192-8. doi:10.1002/ijc.1315.
15. Jang JS, Kim KM, Choi JE, Cha SI, Kim CH, Lee WK, et al. Identification of polymorphisms in the Caspase-3 gene and their association with lung cancer risk. Mol Carcinog. 2008;47(5): 383-90. doi:10.1002/mc.20397.
16. Gangwar R, Mandhani A, Mittal RD. Caspase 9 and caspase 8 gene polymorphisms and susceptibility to bladder cancer in north Indian population. Ann Surg Oncol. 2009;16(7):2028-34. doi: 10.1245/s10434-009-0488-3.
17. Sun T, Gao Y, Tan W, Ma S, Shi Y, Yao J, et al. A six-nucleotide insertion-deletion polymorphism in the CASP8 promoter is associated with susceptibility to multiple cancers. Nat Genet. 2007;39(5):605-13. doi:10.1038/ng2030.
18. Choi JY, Kim JG, Lee YJ, Chae YS, Sohn SK, Moon JH, et al. Prognostic impact of polymorphisms in the CASPASE genes on survival of patients with colorectal cancer. Cancer Res Treat. 2012;44(1):32-6. doi:10.4143/crt.2012.44.1. 32.
19. Shivapurkar N, Reddy J, Chaudhary PM, Gazdar AF. Apoptosis and lung cancer: a review. J Cell Biochem. 2003;88(5):885-98. doi:10.1002/jcb.10440.
20. Turner F, Smith G, Sachse C, Lightfoot T, Garner RC, Wolf CR, et al. Vegetable, fruit and meat consumption and potential risk modifying genes in relation to colorectal cancer. Int J Cancer. 2004;112(2):259-64. doi:10.1002/ijc.20404.
21. Slattery ML, Boucher KM, Caan BJ, Potter JD, Ma KN. Eating patterns and risk of colon cancer. Am J Epidemiol. 1998;148(1):4-16.
22. Miyaki M, Seki M, Okamoto M, Yamanaka A, Maeda Y, Tanaka K, et al. Genetic changes and histopathological types in colorectal tumors from patients with familial adenomatous polyposis. Cancer Res. 1990;50(22):7166-73.
23. Theodoropoulos GE, Michalopoulos NV, Panoussopoulos SG, Taka S, Gazouli M. Effects of caspase-9 and survivin gene polymorphisms in pancreatic cancer risk and tumor characteristics. Pancreas. 2010;39(7):976-80. doi:10.1097/MPA.0b013 e3181d705d4.
24. Yoo SS, Choi JE, Lee WK, Choi YY, Kam S, Kim MJ, et al. Polymorphisms in the CASPASE genes and survival in patients with early-stage non-small-cell lung cancer. J Clin Oncol. 2009;27(34):5823-9. doi:10.1200/JCO.2009.23.1738.
25. Pittman AM, Broderick P, Sullivan K, Fielding S, Webb E, Penegar S, et al. CASP8 variants D302H and -652 6N ins/del do not influence the risk of colorectal cancer in the United Kingdom population. Br J Cancer. 2008;98(8):1434-6. doi:10.1038/sj.bjc.6604314.
26. Haiman CA, Garcia RR, Kolonel LN, Henderson BE, Wu AH, Le Marchand L. A promoter polymorphism in the CASP8 gene is not associated with cancer risk. Nat Genet. 2008;40(3):259-60 (author reply 60-1). doi:10.1038/ng0308-259.
27. Liu B, Zhang Y, Jin M, Ni Q, Liang X, Ma X, et al. Association of selected polymorphisms of CCND1, p21, and caspase8 with colorectal cancer risk. Mol Carcinog. 2010;49(1):75-84. doi:10.1002/mc.20579.
28. Yin M, Yan J, Wei S, Wei Q. CASP8 polymorphisms contribute to cancer susceptibility: evidence from a meta-analysis of 23 publications with 55 individual studies. Carcinogenesis. 2010;31(5):850-7. doi:10.1093/carcin/bgq047.
29. Zhang F, Yang Y, Guo C, Wang Y. CASP8 -652 6N del polymorphism and cancer risk: a meta-analysis of 30 case-control studies in 50 112 subjects. Mutagenesis. 2012. doi:10.1093/mutage/ges019.
30. Liamarkopoulos E, Gazouli M, Aravantinos G, Tzanakis N, Theodoropoulos G, Rizos S, et al. Caspase 8 and caspase 9 gene polymorphisms and susceptibility to gastric cancer. Gastric Cancer. 2011;14(4):317-21. doi:10.1007/s10120-011- 0045-1.
31. Delattre O, Olschwang S, Law DJ, Melot T, Remvikos Y, Salmon RJ, et al. Multiple genetic alterations in distal and proximal colorectal cancer. Lancet. 1989;334(8659):353-6. doi:10.1016/S0140-6736(89)90537-0.
32. Ioannidis JP, Ntzani EE, Trikalinos TA. 'Racial' differences in genetic effects for complex diseases. Nat Genet. 2004;36(12):1312-8. doi:10.1038/ng1474.
33. Chan DS, Lau R, Aune D, Vieira R, Greenwood DC, Kampman E, et al. Red and processed meat and colorectal cancer incidence: meta-analysis of prospective studies. PLoS ONE. 2011;6(6): e20456. doi:10.1371/journal.pone.0020456.
34. Ferguson LR. Meat and cancer. Meat Sci. 2010;84(2):308-13. doi:10.1016/j.meatsci.2009.06.032.
35. Lee SA, Shu XO, Yang G, Li H, Gao YT, Zheng W. Animal origin foods and colorectal cancer risk: a report from the Shanghai Women's Health Study. Nutr Cancer. 2009;61(2): 194-205. doi:10.1080/01635580802419780.